Clinical Trial Update: PK, Dose Proportionality, Food Effect And Repeat Dose Study Of Rosiglitazone XR In Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacokinetics, dose proportionality, food effect and repeat-dose safety of rosiglitazone XR in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Rosiglitazone XR (rosiglitazone extended-release)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED